대한약침학회지 (Journal of Pharmacopuncture)

  • 제23권4호
  • /
  • Pages.237-246
  • /
  • 2020
  • /
  • 2093-6966(pISSN)
  • /
  • 2234-6856(eISSN)
대한약침학회 (KOREAN PHARMACOPUNCTURE INSTITUTE)
권호 표지
DOI QR코드

DOI QR Code

Genotoxicity Evaluation of Capsaicin-Containing (CP) Pharmacopuncture, in an In Vivo Micronucleus Test

  • Hwang, Ji Hye (Department of Acupuncture & Moxibustion Medicine, College of Korean Medicine, Gachon University) ;
  • Ku, Jaseung (Bogwang Korean Medical Clinic) ;
  • Jung, Chul (Namsangcheon Korean Medicine Clinic)
  • 투고 : 2020.09.25
  • 심사 : 2020.11.12
  • 발행 : 2020.12.31
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Objectives: Capsaicin-containing (CP) pharmacopuncture was developed to treat neuropathic pain. This study was conducted to assess the toxicity of CP extract for pharmacopuncture, using a micronucleus test. Methods: First, a dose range finding study was conducted. Then an in vivo micronucleus test was performed to determine the induction of micronuclei in mouse bone marrow cells after intramuscular administration of CP twice with a 24-hour interval to 8-week-old ICR mice. A high dose of 0.2 mL/animal was selected, and this was sequentially diluted by applying a geometric ratio of 2 to produce two lower dose levels (0.1 and 0.05 mL/animal). In addition, negative and positive control groups were set up, and an HPLC analysis was conducted to confirm the capsaicin content of CP. Results: The incidence of micro-nucleated polychromatic erythrocytes in polychromatic erythrocytes in the CP-treated group was similar to that in the negative-control group, while that in the positive-control group was significantly greater. In addition, the ratio of polychromatic erythrocytes to total erythrocytes in the CP treatment group and the positive control group was not significantly different from the negative control group. In the HPLC analysis, capsaicin in the CP was identified through a comparison with the retention time of the capsaicin standard of 27 min. Conclusion: CP did not show any indication of any potential to induce micronuclei formation in bone marrow cells of ICR mice under the conditions of this study. Further toxicity studies are necessary to ensure the safety of the use of CP in clinical practice.

키워드

참고문헌

  1. Singletary K. Red pepper: overview of potential health benefits. Nutr Today. 2011;46(1):33-47. https://doi.org/10.1097/NT.0b013e3182076ff2
  2. Pawar SS, Bharude NV, Sonone SS, Deshmukh RS, Raut AK, Umarkar AR. Chillies as food, spice and medicine: a perspective. Int J Pharm Biol Sci. 2011;1(3):311-8.
  3. Silva C, Rio ME, Cruz F. Desensitization of bladder sensory fibers by intravesical resiniferatoxin, a capsaicin analog: long-term results for the treatment of detrusor hyperreflexia. Eur Urol. 2000;38(4):444-52. https://doi.org/10.1159/000020322
  4. McCarty MF, DiNicolantonio JJ, O'Keefe JH. Capsaicin may have important potential for promoting vascular and metabolic health. Open Heart. 2015;2(1):e000262. https://doi.org/10.1136/openhrt-2015-000262
  5. Ito K, Nakazato T, Yamato K, Miyakawa Y, Yamada T, Hozumi N, et al. Induction of apoptosis in leukemic cells by homovanillic acid derivative, capsaicin, through oxidative stress: implication of phosphorylation of p53 at Ser-15 residue by reactive oxygen species. Cancer Res. 2004;64(3):1071-8. https://doi.org/10.1158/0008-5472.CAN-03-1670
  6. Hail N Jr, Lotan R. Examining the role of mitochondrial respiration in vanilloid-induced apoptosis. J Natl Cancer Inst. 2002; 94(17):1281-92. https://doi.org/10.1093/jnci/94.17.1281
  7. Stander S, Luger T, Metze D. Treatment of prurigo nodularis with topical capsaicin. J Am Acad Dermatol. 2001;44(3):471-8. https://doi.org/10.1067/mjd.2001.110059
  8. Jung C, Jung JH, Lee MS. A clinical study of immune pharmacopuncturology. Yeongi: Kyungrak Medical Publishing Co.; 2011. p. 127-33.
  9. Korean Acupuncture and Moxibustion Society. Acupuncture medicine. Seoul: Hanmi Medical Publishing Co.; 2020. 932 p.
  10. Kim HJ, Gwan R, Han JW, Jung C. Anti-oxidant anti-inflammatory effects of V Yakchim. J Korea Immuno-Yakchim Soc. 2013; 2(1):1-8.
  11. Jung C. In vivo micronucleus test of V-YAKCHIM in ICR mice. J Korea Immuno-Yakchim Soc. 2013;2(2):5-10.
  12. Cho S, Jung C, Kim K, Ko S, Jung H, Park J. A case study of acute appendicitis improved by pharmacopuncture treatment. J Intern Korean Med. 2019;40(2):208-19. https://doi.org/10.22246/jikm.2019.40.2.208
  13. Chung YJ, Lee HJ, Lee YK, Lee JH, Gong HM, Jun SA, et al. Case report of hypoesthesia of lower limb with additional CP pharmacopuncture. J Physiol Pathol Korean Med. 2019;33(2):158-62. https://doi.org/10.15188/kjopp.2019.04.33.2.158
  14. Jeong JH, Hwang JH. Korean medicine treatment including capsaicin-containing (CP) pharmacopuncture for acute low back and hip pain: a case report of 3 patients. Korean J Acupunct. 2020;37(3):191-7. https://doi.org/10.14406/acu.2020.020
  15. Hwang JH, Ku J, Jung C. Evaluation of the single-dose toxicity of capsaicin pharmacopuncture in rats. J Acupunct Res. 2020; 37(3):167-72. https://doi.org/10.13045/jar.2020.00185
  16. Hwang JH, Ku J, Jung C. Bacterial reverse mutation test of CP pharmacopunture. J Korean Med. 2020;41(3):55-68. https://doi.org/10.13048/jkm.20025
  17. Korea Food and Drug Administration (KFDA). Good Laboratory Practice (GLP). [Internet]. Cheongju: KFDA; c2017 [cited 2017 May 1]. Available from: http://www.law.go.kr/admRulInfoP.do?admRulSeq=2100000086689.
  18. Korea Food and Drug Administration (KFDA). Partial Amendment Official Announcement about Toxicity Test for Drug [Internet]. Cheongju: KFDA; 2015 Nov 11 [updated 2015 Nov 11; cited 2015 Nov 11]. Available from: https://www.law.go.kr/LSW/admRulLsInfoP.do?chrClsCd=010202&admRulSeq=2100000032147.
  19. Organisation for Economic Co-operation and Development (OECD). ENV/MC/CHEM(98)17: OECD series on principles of good laboratory practice and compliance monitoring number 1. Paris: OECD; 1998. 41 p
  20. Diehl KH, Hull R, Morton D, Pfister R, Rabemampianina Y, Smith D, et al. A good practice guide to the administration of substances and removal of blood, including routes and volumes. J Appl Toxicol. 2001;21(1):15-23. https://doi.org/10.1002/jat.727
  21. Teschke R, Wolff A, Frenzel C, Schulze J. Review article: herbal hepatotoxicity--an update on traditional Chinese medicine preparations. Aliment Pharmacol Ther. 2014;40(1):32-50. https://doi.org/10.1111/apt.12798
  22. Kim EJ, Chen Y, Huang JQ, Li KM, Razmovski-Naumovski V, Poon J, et al. Evidence-based toxicity evaluation and scheduling of Chinese herbal medicines. J Ethnopharmacol. 2013;146(1):40-61. https://doi.org/10.1016/j.jep.2012.12.027
  23. Lee MY, Seo CS, Kim JY, Shin HK. Genotoxicity evaluation of Guibi-Tang extract using an in vitro bacterial reverse mutation assay, chromosome aberration assay, and in vivo micronucleus test. BMC Complement Altern Med. 2014;14:215. https://doi.org/10.1186/1472-6882-14-215
  24. Kirsch-Volders M, Sofuni T, Aardema M, Albertini S, Eastmond D, Fenech M, et al. Report from the in vitro micronucleus assay working group. Mutat Res. 2003;540(2):153-63. https://doi.org/10.1016/j.mrgentox.2003.07.005